ADUS:NSD-Addus HomeCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 132.52

Change

+0.05 (+0.04)%

Market Cap

USD 2.40B

Volume

0.12M

Analyst Target

USD 119.88
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas. Address: 6303 Cowboys Way, Frisco, TX, United States, 75034

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

-1.03 (-0.68%)

USD 8.72B
ACHC Acadia Healthcare Company Inc

+0.17 (+0.22%)

USD 7.24B
OPCH Option Care Health Inc

-0.15 (-0.48%)

USD 5.55B
SGRY Surgery Partners Inc

+0.78 (+2.49%)

USD 3.94B
AMED Amedisys Inc

-0.22 (-0.23%)

USD 3.18B
LFST Lifestance Health Group Inc

-0.09 (-1.32%)

USD 2.67B
ASTH Astrana Health Inc

+1.68 (+3.03%)

USD 2.61B
AVAH Aveanna Healthcare Holdings In..

N/A

USD 1.02B
HCSG Healthcare Services Group Inc

+0.13 (+1.13%)

USD 0.82B
CMPS Compass Pathways Plc

+0.08 (+1.11%)

USD 0.50B

ETFs Containing ADUS

SBM 7.23 % 0.95 %

N/A

N/A
SMN ProShares UltraShort Basi.. 7.23 % 0.95 %

+0.06 (+-0.10%)

N/A
JHMA 4.37 % 0.47 %

N/A

N/A
XLPE:LSE Xtrackers LPX Private Equ.. 3.49 % 0.00 %

-131.00 (-0.10%)

N/A
SXLB:LSE SPDR S&P U.S. Materials S.. 3.31 % 0.00 %

-0.32 (-0.10%)

N/A
IMSU:LSE iShares S&P 500 Materials.. 3.29 % 0.00 %

-7.75 (-0.10%)

N/A
XLB Materials Select Sector S.. 3.26 % 0.13 %

-0.40 (-0.10%)

USD 5.32B
UYM ProShares Ultra Basic Mat.. 2.26 % 0.95 %

-0.24 (-0.10%)

N/A
VVAL:LSE 0.54 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.09 % 0.00 %

-0.05 (-0.10%)

N/A
BIV Vanguard Intermediate-Ter.. 0.05 % 0.07 %

-0.24 (-0.10%)

N/A
BLV Vanguard Long-Term Bond I.. 0.04 % 0.07 %

-0.64 (-0.10%)

N/A
BSV Vanguard Short-Term Bond .. 0.02 % 0.07 %

-0.09 (-0.10%)

N/A
SCHZ Schwab U.S. Aggregate Bon.. 0.01 % 0.04 %

-0.10 (-0.10%)

USD 8.44B
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

+0.11 (+-0.10%)

USD 0.09B
WMCR 0.00 % 0.50 %

N/A

N/A
SCHI Schwab 5-10 Year Corporat.. 0.00 % 0.00 %

-0.12 (-0.10%)

USD 7.47B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 42.72% 92% A 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.72% 92% A 89% A-
Trailing 12 Months  
Capital Gain 55.76% 88% B+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.76% 88% B+ 87% B+
Trailing 5 Years  
Capital Gain 62.82% 60% D- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.82% 60% D- 74% C
Average Annual (5 Year Horizon)  
Capital Gain 5.64% 54% F 59% D-
Dividend Return 5.64% 54% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.85% 96% N/A 74% C
Risk Adjusted Return 25.81% 67% D+ 59% D-
Market Capitalization 2.40B 70% C- 81% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.